In a large cohort of patients receiving kidney dialysis, those randomized to high-dose cholecalciferol for up to 7.5 years showed no significant reductions in death.

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

Adding tarlatamab to durvalumab as first-line maintenance therapy in patients with extensive-stage small cell lung cancer improved overall survival by more than 8 months. Patients who received the ...

An individualized mRNA-based cancer vaccine reduces melanoma recurrence and distant metastasis when added to immunotherapy, marking a potential milestone for personalized cancer treatment.

Everyday medical equipment is shedding micro- and nanoplastics into patients, bypassing their bodies’ natural filters and ...

Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...

Energy drink use in adolescents may be a marker of sleep debt, and clinicians should treat it as a cue to screen for short ...

A pooled phase 3 analysis shows that 15-mg and 20-mg doses of estetrol both reduce the frequency and severity of ...

Upadacitinib, a JAK1 inhibitor, is linked to a lower risk for treatment failure and more steroid-free disease stability than ...

Synthesizing medical management strategies with surgical and interventional treatments improves outcomes in patients with ...

Compared with the traditional diet, the low-carbohydrate diet reduced insulin requirements by 0.08 IU/kg, or 7.4 IU/d, and ...

As cases rise in that state, CDC shares tips with clinicians on how to recognize and treat the mosquito-borne virus.